AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹2,320 Cr | ₹1,834 Cr | ₹1,827 Cr | ₹1,686 Cr | ₹1,617 Cr |
What is the latest Net Current Assets ratio of AJANTA PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹2,320 Cr |
| Mar2025 | ₹1,834 Cr |
| Mar2024 | ₹1,827 Cr |
| Mar2023 | ₹1,686 Cr |
| Mar2022 | ₹1,617 Cr |
How is Net Current Assets of AJANTA PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,320 Cr | 26.51 | |
| Mar2025 | ₹1,834 Cr | 0.37 | |
| Mar2024 | ₹1,827 Cr | 8.36 | |
| Mar2023 | ₹1,686 Cr | 4.26 | |
| Mar2022 | ₹1,617 Cr | - | |
Compare Net Current Assets of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹41,281.9 Cr | -0.6% | 9.7% | 28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.6% |
9.7% |
28.7% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses